AirDuo Digihaler: payments to doctors
Payments that named AirDuo Digihaler as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $545K
- Providers
- 8,687
- Transactions
- 22,136
- Average per transaction
- $25
The per-transaction average — $25 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 8,687 providers the average total is $63, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $544,633 | 100.0% |